Find Funding Opportunities

NOITP for RFA-MH-21-235 This Funding Opportunity Announcement (FOA) intends to support a group of large-scale Comprehensive Centers that will adopt scalable technology platforms and streamlined sampling strategies and assay cascade to create comprehensive and highly granular brain cell atlases of human and non-human primates with an emphasis on human. The Centers are expected to characterize all brain cell types (neurons, glia, and other non-neuronal cells) at high-resolution. The overarching goal of the BICAN is to build reference brain cell atlases that will be widely used throughout the research community, providing a molecular and anatomical foundational framework for the study of brain function and disorders.

NOITP for RFA-MH-21-236 This Funding Opportunity Announcement (FOA) intends to support a group of Specialized Collaboratories that will adopt scalable technology platforms and streamlined sampling strategies and assay cascade to create comprehensive and highly granular brain cell atlases in human, non-human primates, and mouse, in coordination and collaboration with other BICAN projects. In particular, the Specialized Collaboratories are expected to complement the Comprehensive Centers in BICAN with distinct capabilities, competencies, and research aims. The overarching goal of the BICAN is to build reference brain cell atlases that will be widely used throughout the research community, providing a molecular and anatomical foundational framework for the study of brain function and disorders.

NOITP for RFA-MH-21-237 This Funding Opportunity Announcement (FOA) intends to support a Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) that will be composed of four components to establish respectively (1) a common sequencing data processing pipeline, (2) a common imaging data processing pipeline, (3) a comprehensive brain cell knowledge base, and (4) an engaging and outreach component to coordinate the research within and beyond BICAN. The overall goals of CUBIE are to (i) enable the exploration of large-scale brain cell atlas data and knowledge, and inspire research in brain function and disorders; and (ii) ensure research rigor and data reproducibility by making the data to be findable, accessible, interoperable, and reusable, and the process transparent. An application is expected to propose only one of the above four respective components.

This is a time-sensitive Request for Information (RFI) to solicit input regarding revisions to the NIH Sleep Disorders Research Plan. It is issued by the National Heart, Lung, and Blood Institute (NHLBI), the National Center on Sleep Disorders Research (NCSDR), on behalf of the trans-NIH Sleep Research Coordinating Committee (SRCC).

The purpose of this Notice is to extend the expiration date of PAR-19-159, "Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)" by one year. PAR-19-159 will now expire on May 8, 2022.

The National Institute of Neurological Disorders and Stroke (NINDS) announces the early termination of PAR-21-162, Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional).

The National Institute of Neurological Disorders and Stroke (NINDS) announces the early termination of PAR-21-152, NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed).

This Notice is to inform potential applicants that the National Center for Complementary and Integrative Health (NCCIH) and the National Institute of Neurological Disorders and Stroke (NINDS) will hold a pre-application technical assistance webinar on RFA-AT-21-006, "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)". The date and time for the webinar are listed below. The intent of this webinar is to provide an overview of the initiative and guidance on application preparation and to address applicant questions. The webinar is optional and not required for application submission.

The purpose of this Notice is to inform interested applicants that the expiration date in PAR-18-205 " NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional)" will be extended by one receipt cycle (See changes in bold italics below). Part 1. Overview Key Dates Currently Reads: Expiration Date January 8, 2021 Modified to Read: Expiration Date May 8, 2021 All other aspects of this FOA remain unchanged.

The purpose of this Request for Information (RFI) is to gain feedback, comments, and novel ideas from the members of scientific communities in the United States (U.S.) and abroad as well as from persons representing other segments of American public to help identify the needs and priorities in this area of science, and plan future activities and initiatives that can most significantly enhance the research in chronotherapy, circadian-based medicine or chronomedicine and greater benefit of the biomedical research community.